Relative bioavailability of different oral sustained release oxprenolol tablets

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 1998, Pages 178-184

  Leucuta, S E ^a   Follidis, M ^a   Capalneanu, R ^a   Mocan, A ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Bioavailability; Formulations; Oxprenolol; Sustained release

Indexed keywords

OXPRENOLOL;

ADULT; BIOEQUIVALENCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUSTAINED RELEASE FORMULATION; TABLET;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; HUMANS; MALE; OXPRENOLOL; TABLETS;

EID: 0031660138     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189336     Document Type: Conference Paper

References (14)

1. Kendall M.J., John V.A. (1983): Oxprenolol: clinical pharmacology, pharmacokinetics and pharmacodynamics, Am. J. Cardiol., 52, 27 D-33D
2. Mason W.D.,Winer N. (1976): Pharmacokinetics of oxprenolol in normal subjects, Clin. Pharmacol. Ther., 20, 401-412
3. Kydonieus A. (ed.) (1992): Treatise on Controlled Drug Delivery, New York: Dekker, Inc.
4. Skelly J.P., Amidon G.L., Barr et al. (1990): Report of the workshop on: in vitro and in vivo testing and correlation for oral controlled / modified release dosage forms, Int. J. Pharm., 63, 83-93
5. Follidis M. (1994): Oral controlled-release systems with oxprenolol, Thesis, University of Medicine and Pharmacy, Cluj-Napoca, Romania
6. Follidis M., Leucuta S.E. (1991): Oral controlled-release dosage forms with oxprenolol: hydrophilic matrix and floating tablets, Proceedings of the 10th Pharmaceutical Technology Conference,Bologna,Italy, Solid Oral Research Unit(ed.), Vol.1, 52-65
7. Follidis M., Leucuta S.E. (1992): Oral megaloporous system containing oxprenolol microspheres: in vitro kinetics and pharmacokinetics in man, 6-ème Congrès International de Technologie Pharmaceutique, APGI (ed.), Paris, Vol.1, 73-80
8. Sioufi A., Collussi D., Mangoni P. (1983): Gaschromatographic determination of oxprenolol in human plasma, J. Chromatogr., 278, 183-188
9. Leucuta S.E., Pop R.D. (1981): Farmacocinetica, Editura Dacia, Cluj-Napoca, pp. 16-82
10. Gibaldi M., Perrier D. (1992): Pharmacokinetics, 2nd ed., M. Dekker, New York, 444-449
11. Schulz H.U., Steinijans V.W. (1992): Striving for standards in bioequivalence assessement, Int. J. Clin. Pharmacol. Ther. Toxicol. 30,S1-S6
12. DeHaan P., Lerk C.F. (1986): The megaloporous system:a novel principle for zero-order drug delivery. I. In vitro and in vivo performance, Int. J. Pharm., 31, 15-24
13. Moës A.J. (1993): Gastroretentive dosage dorms, Crit. Rev. Ther. Drug Carr. Syst., 10, 143-195
14. Steinijans V.W. (1990): Pharmacokinetic characterization of controlled-release formulatins, Eur. J. Drug Metab. Pharmacokin., 15, 173-181